Cumberland Pharmaceuticals (CPIX) Accumulated Expenses (2011 - 2026)
Cumberland Pharmaceuticals (CPIX) posted Accumulated Expenses of $17.6 million for Q4 2022, up 102.9% sequentially from $8.7 million in Q4 2021, and up 102.9% YoY from $8.7 million in Q4 2021.
Cumberland Pharmaceuticals (CPIX) Accumulated Expenses (2011 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has reported Accumulated Expenses for 12 years, with the latest figure at $17.6 million in Q4 2022.
- Quarterly Accumulated Expenses rose 102.9% year-over-year to $17.6 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $17.6 million (up 102.9% YoY) and the FY2022 annual result came in at $17.6 million, up 102.9% from the prior year.
- Accumulated Expenses advanced to $17.6 million in Q4 2022 per CPIX's latest filing, from $8.7 million in the prior quarter.
- Over five years, Accumulated Expenses peaked at $17.6 million in Q4 2022 and troughed at $8.7 million in Q4 2021.
- A 5-year average of $13.1 million and a median of $11.3 million in 2020 frame the typical range for Accumulated Expenses.
- The sharpest annual moves came in 2019 and 2022: Accumulated Expenses slumped 33.67% in 2019, then surged 102.9% in 2022.
- Over 5 years, Accumulated Expenses stood at $16.7 million in 2018, then plunged by 33.67% to $11.1 million in 2019, then advanced by 1.53% to $11.3 million in 2020, then slipped by 22.98% to $8.7 million in 2021, then soared by 102.9% to $17.6 million in 2022.
- According to Business Quant data, Accumulated Expenses over the past three periods registered $17.6 million, $8.7 million, and $11.3 million for Q4 2022, Q4 2021, and Q4 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Cumberland Pharmaceuticals | 114.68 Mn | 110.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.52 Mn |
| Dec 31, 2025 | 7.77 Mn |
| Dec 31, 2022 | 17.59 Mn |
| Dec 31, 2021 | 8.67 Mn |
| Dec 31, 2020 | 11.25 Mn |
| Dec 31, 2019 | 11.08 Mn |
| Dec 31, 2018 | 16.71 Mn |
| Dec 31, 2017 | 8.71 Mn |
| Dec 31, 2016 | 6.76 Mn |
| Dec 31, 2015 | 9.53 Mn |
| Dec 31, 2014 | 10.51 Mn |
| Dec 31, 2013 | 5.51 Mn |
| Dec 31, 2012 | 5.26 Mn |
| Dec 31, 2011 | 5.09 Mn |